SEC Form 4 · accession 0001127602-18-036101
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan Goldstein
Officer — VP, Corporate Controller
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 10, 2018 | M | 1,457 | $34.21 | A | 4,911 | D | |
| Common StockF2 | Dec 10, 2018 | S | 1,693 | $102.91 | D | 3,218 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F3 | $34.21 | Dec 10, 2018 | M | 1,457 | D | Oct 25, 2017 | Oct 25, 2023 | Common Stock | 1,457 | 2,913 | D |
Explanation of responses
- F1Transaction pursuant to an existing 10b5-1 trading plan.
- F2This number includes unvested restricted stock units previously reported.
- F3Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.